Deuterated camptothecin compound, and preparation therefor and use thereof
AssigneeShanghai Qilu Pharmaceutical Research and Development Centre Ltd.
InventorsWei LV, Jiyu JIN, Chen JIN, Yang YANG, Ying HUANG, Weikang TAO
Life of this patent
Estimating the term…
Abstract
Disclosed are a deuterated camptothecin compound as represented by formula II and a pharmaceutically acceptable salt thereof, a preparation method therefor, a pharmaceutical composition containing the deuterated camptothecin compound or a pharmaceutically acceptable salt thereof, and the use thereof in the treatment of tumor-related diseases. Such deuterated camptothecin compound has excellent drug activity and pharmacokinetic properties, and has reduced in-vivo toxicity and improved in-vivo safety.
Claims21
A compound of Formula II, a pharmaceutically acceptable salt thereof, or a stereoisomer thereof:
- wherein R1 is H, halogen, OH, SH, NH2, C1-4 alkyl, C1-4 haloalkyl, or C1-4 alkoxy;
- R2 is H, halogen, C1-4 alkyl, or C1-4 alkoxy;
- or R1 and R2 are cyclized to form —O—(CH2)m—O—, wherein m is 1, 2, or 3;
- R3 and R4 are each independently H, C1-4 alkyl, C1-4 alkoxy, C1-4 haloalkyl, or C1-4 haloalkoxy;
- or R3 and R4 are cyclized to form —(CH2)k—, wherein k is 1, 2, 3, or 4;
- X is H, OH, HO—CH(R5)—(CH2)p—CO—NH—, or —N(R6)(R7), wherein p is 0, 1, or 2;
- R5 is H, C1-4 alkyl, C1-4 haloalkyl, 3- to 6-membered cycloalkyl, or 3- to 6-membered heterocycloalkyl;
- R6 is H, C1-4 alkyl, or C1-4 haloalkyl;
- R7 is H or R8—S(O)2—;
- R8 is C1-4 alkyl;
- and
- t is 0, 1, 2, 3, 4, or 5;
- and the compound of Formula II excludes any one of the following compounds:
A compound, a pharmaceutically acceptable salt thereof, or a stereoisomer thereof, wherein the compound is selected from
(canceled)
Dependencies are inferred from the claim text.